20 May 2013
Keywords: approval, merck, prostate, drug, received, usa, market
Article | 29 June 1992
Merck has received approval in the USA to market its 5-alpha reductase inhibitor, Proscar (finasteride), for the treatment of benign ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.